Fate Therapeutics's market cap is currently $174.26M. The company's EPS TTM is $-1.654; its P/E ratio is ―; Fate Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 63.53M	$ 96.30M	$ 55.85M	$ 31.43M	$ 10.68M
Gross Profit	$ -98.16M	$ 82.54M	$ 50.00M	$ -94.19M	$ -77.09M
Operating Income	$ -190.51M	$ -308.39M	$ -216.99M	$ -128.09M	$ -100.73M
EBITDA	$ -172.23M	$ -294.63M	$ -211.14M	$ -125.00M	$ -94.20M
Net Income	$ -160.93M	$ -255.06M	$ -206.30M	$ -170.30M	$ -97.71M
Balance Sheet
Cash & Short-Term Investments	$ 315.18M	$ 436.23M	$ 615.91M	$ 482.92M	$ 221.43M
Total Assets	$ 506.22M	$ 705.56M	$ 921.46M	$ 622.46M	$ 302.27M
Total Debt	$ 103.54M	$ 109.34M	$ 114.82M	$ 97.30M	$ 26.93M
Net Debt	$ 61.67M	$ 48.01M	$ -18.77M	$ -70.05M	$ -72.89M
Total Liabilities	$ 137.80M	$ 221.62M	$ 242.62M	$ 238.01M	$ 57.52M
Stockholders' Equity	$ 368.42M	$ 483.94M	$ 678.84M	$ 384.44M	$ 244.76M
Cash Flow
Free Cash Flow	$ -138.42M	$ -283.77M	$ -213.57M	$ -44.16M	$ -90.57M
Operating Cash Flow	$ -132.26M	$ -248.21M	$ -162.87M	$ -39.23M	$ -83.17M
Investing Cash Flow	$ 112.67M	$ 166.75M	$ -324.02M	$ -161.08M	$ -157.45M
Financing Cash Flow	$ 85.00K	$ 9.21M	$ 453.13M	$ 282.84M	$ 149.93M

Currency in USD

Fate Therapeutics Earnings and Revenue History

Income Statement >

Fate Therapeutics Debt to Assets

Balance Sheet >

Fate Therapeutics Cash Flow

Cash Flow >

Fate Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing